• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBristol Myers Squibb

Bristol Myers Squibb

C-SuiteBristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent cliff’ plan
By Diane BradyDecember 5, 2025
Cancer vaccination, conceptual illustration
HealthPersonalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By Lindsey LeakeFebruary 7, 2025
A researcher examining a slide while standing with coworker in background at laboratory
Health20 innovative breakthroughs that will transform your health
By Erika FryDecember 18, 2024
CommentaryDeveloping new medicines for everyone, everywhere, equally
By Giovanni Caforio, MDNovember 13, 2023
Board members in discussion at conference table in office
NewslettersHere’s what differentiates the top 25 corporate boards from their counterparts
By Lila MacLellanMay 12, 2023
François Locoh-Donou, CEO of F5 sits on a chair in his living room
LeadershipThese 25 companies have the most ‘modern’ boards. Here’s what that means
By Lila MacLellanMay 10, 2023
Bristol-Myers Squibb logo on a smartphone
NewslettersWhat a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.
By Jeremy Kahn and Jonathan VanianJanuary 25, 2022
ConferencesLeaders from Peloton, Chobani, and more on how brands earn their purpose
By Lydia BelangerOctober 13, 2021
Moderna vaccine
HealthBooster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By Sy MukherjeeAugust 5, 2021
A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
TechBritish A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By Jeremy KahnJune 15, 2021
HealthSeniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
By Harris Meyer and Kaiser Health NewsDecember 28, 2020
FinanceWarren Buffett is going all in on the vaccine rally, piling into these stocks
By Katherine Chiglinsky and BloombergNovember 17, 2020
Key Speakers At The 2017 Milken Conference
NewslettersBristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem
By Sy MukherjeeOctober 1, 2020
HealthDiversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
By Sy MukherjeeAugust 12, 2020
American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Fortune Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
NewslettersHealthcare is in the midst of a ‘paradigm shift’
By Katherine Dunn and Alan MurrayJuly 8, 2020
1
  • 1
  • 2
  • 3
3
Most Popular
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants is ‘pure fantasy thinking’An image of a popular article
By Marco Quiroz-GutierrezFebruary 25, 2026
Commentary
'The Pitt': a masterclass display of DEI in action An image of a popular article
By Robert RabenFebruary 26, 2026
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.